How pharma and digital solutions can improve patient care: Spinal Muscular Atrophy
Updated: Apr 30, 2022
Spinal Muscular Atrophy (SMA) is a rare disease affecting the motor nerve cells in the spinal cord. It’s a debilitating condition that affects 1 per 8,000 to 10,000 people worldwide, impacting their ability to walk, eat, and breathe. SMA Type 1 represents an estimated 50% of all cases, for which life expectancy is less than 18 months without treatment.
This SMA Awareness month, we look at how digital health solutions can complement and enhance the effectiveness of drug-based treatments for rare diseases and make a positive difference in the life of patients.
SMA Awareness Month: How pharma and digital solutions can improve patient care - (pharmaphorum.com)